The levels of ANOS1 were significantly elevated in patients with stage I GC compared with H controls (median 1179 ng/mL and 461 ng/mL, respectively, p < 0.0001), whereas they were equivalent in patients with GC stages I and II–IV. This evidence concerns the gene ANOS1 and gastric cancer.